Publicacións en colaboración con investigadores/as de Hospital Ramón y Cajal (44)

2024

  1. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism

    Frontiers in Endocrinology, Vol. 15

  2. Impact of primary aldosteronism on kidney function: Results from the SPAIN-ALDO registry

    Journal of Hypertension, Vol. 42, Núm. 10, pp. 1805-1812

  3. Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes

    European Journal of Clinical Investigation, Vol. 54, Núm. 8

  4. Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register

    Endocrine, Vol. 84, Núm. 2, pp. 683-693

  5. Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry

    High Blood Pressure and Cardiovascular Prevention, Vol. 31, Núm. 1, pp. 43-53

2023

  1. Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes

    Endocrine Connections, Vol. 12, Núm. 9

  2. Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 1, pp. e379-e388

  3. Prevalence, risk factors and evolution of diabetes mellitus after treatment in primary aldosteronism. Results from the SPAIN-ALDO registry

    Journal of Endocrinological Investigation, Vol. 46, Núm. 11, pp. 2343-2352

2022

  1. Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register)

    Endocrine, Vol. 78, Núm. 2, pp. 363-372

  2. Differences in the presentation and evolution of primary aldosteronism in elderly (≥65 years) and young patients (<65 years)

    Endocrine Connections, Vol. 11, Núm. 6

  3. Evolution of the cardiometabolic profile of primary hyperaldosteronism patients treated with adrenalectomy and with mineralocorticoid receptor antagonists: results from the SPAIN-ALDO Registry

    Endocrine, Vol. 76, Núm. 3, pp. 687-696

  4. Executive summary of the consensus statement of: Clinical recommendations for sport practice in people with diabetes (RECORD Guide). Update 2021. Diabetes Mellitus Area of the Spanish Society of Endocrinology and Nutrition (SEEN)

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 9, pp. 732-743

  5. Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study

    European Thyroid Journal, Vol. 11, Núm. 5

  6. Predictive model of hypertension resolution after adrenalectomy in primary aldosteronism: the SPAIN-ALDO score

    Journal of Hypertension, Vol. 40, Núm. 12, pp. 2486-2493

  7. Registro del Grupo NADYA-SENPE de Nutrición Enteral Domiciliaria en España: años 2018 y 2019

    Nutricion hospitalaria, Vol. 39, Núm. 1, pp. 223-229

2021

  1. Erratum: Late Recovery of Parathyroid Function after Total Thyroidectomy: A Case-Control Study (Horm Metab Res (2021) 53 DOI: 10.1055/a-1608-1373)

    Hormone and Metabolic Research

  2. Late Recovery of Parathyroid Function after Total Thyroidectomy: A Case-Control Study

    Hormone and Metabolic Research, Vol. 53, Núm. 10, pp. 654-661

  3. Recovery of parathyroid function in patients with thyroid cancer treated by total thyroidectomy: An analysis of 685 patients with hypoparathyroidism at discharge of surgery

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 6, pp. 398-407

  4. Thyroid lobectomy in patients with differentiated thyroid cancer: an analysis of the clinical outcomes in a nationwide multicenter study

    Gland Surgery, Vol. 10, Núm. 1, pp. 678-689

2020

  1. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review

    Clinical Nutrition, Vol. 39, Núm. 8, pp. 2368-2388